ShareHope Medicine Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 11, 2022
Share
ShareHope Medicine Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 1,115.8 million compared to TWD 942.41 million a year ago. Net income was TWD 102.64 million compared to TWD 38.65 million a year ago. Basic earnings per share from continuing operations was TWD 0.8571 compared to TWD 0.3238 a year ago. Diluted earnings per share from continuing operations was TWD 0.8476 compared to TWD 0.3238 a year ago.
For the six months, sales was TWD 2,156.25 million compared to TWD 1,844.23 million a year ago. Net income was TWD 219.23 million compared to TWD 91.78 million a year ago. Basic earnings per share from continuing operations was TWD 1.8286 compared to TWD 0.7619 a year ago. Diluted earnings per share from continuing operations was TWD 1.8095 compared to TWD 0.7429 a year ago.
ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.
SHAREHOPE MEDICINE CO., LTD. 
